GenoScreen is an innovative company specializing in the field of genomics, offering genomic services and cutting-edge solutions. Established in 2001 and headquartered in France, it utilizes advanced technologies to analyze and interpret DNA-encoded information, catering to various sectors including healthcare, environment, agronomy, agriculture, agri-food, and skincare. The company provides an array of services such as molecular biology analyses, deep sequencing-based kits for microbial diagnosis, and expert consultancy services for genomics projects. Notably, GenoScreen also offers customized training programs for individuals seeking to enhance their understanding of genomic analyses. With over 20 years of expertise in genomics, GenoScreen boasts a team of 40 employees30% of its turnover reinvested in this area. Its global reach is underscored by its customer base spanning 50 countries400 active clients. The company holds ISO certifications ISO13485 & ISO9001, further reflecting its dedication to quality and compliance. Notably, the company received a Venture Round investment from FINORPA in January 2005, signaling external validation and support for its innovative pursuits in the genomics space. As GenoScreen continues to drive advancements in biotechnology and healthcare, its strong foundation, diverse offerings, and ongoing investment in R&D position it as a noteworthy player in the genomics industry.
No recent news or press coverage available for GenoScreen.